Organization
Department of Experimental Oncology
2 abstracts
Abstract
Histopathological response (HR) after neoadjuvant chemotherapy (ChT) for high-risk soft tissue sarcomas (STS): A planned analysis of the ISG-STS-1001 trial.Org: Department of Experimental Oncology, Milano, Italy, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Vall d'Hebron University Hospital, Bergonié Institute,
Abstract
Effect of SNPs in TMPRSS2 to severe COVID-19 in patients with prostate cancer.Org: Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Molecular Immunology Unit, Department of Experimental Oncology, Programma Prostata,